» Articles » PMID: 37767043

Box-Behnken Design of Thermo-responsive Nano-liposomes Loaded with a Platinum(iv) Anticancer Complex: Evaluation of Cytotoxicity and Apoptotic Pathways in Triple Negative Breast Cancer Cells

Overview
Journal Nanoscale Adv
Specialty Biotechnology
Date 2023 Sep 28
PMID 37767043
Authors
Affiliations
Soon will be listed here.
Abstract

Herein, thermo-responsive liposomes (TLs) loaded with Asp (Asp/TLs) were produced by self-assembling DPPC, DSPE-PEG2000, and cholesterol. The preparation variables were optimized using the Box-Behnken design (BBD). The optimized Asp/TLs exhibited an average particle size of 114.05 ± 1.56 nm, PDI of 0.15 ± 0.015, zeta potential of -15.24 ± 0.65 mV, and entrapment efficiency (EE%) of 84.08 ± 2.75%. In addition, under physiological conditions, Asp/TLs showed spherical shape, outstanding stability and thermo-triggered the release of Asp at 38 °C, reaching the maximum Asp release at 40 °C. The MTT assay showed that the optimal Asp/TLs exhibited the highest cytotoxic activity upon exposure to mild hyperthermia (40 °C) against the invasive triple-negative breast cancer cell line (MDA-MB-231) when compared to other preparations. The IC of Asp/TLs (40 °C) was estimated at 0.9 μg mL, while that of free Asp (40 °C) was 3.83 μg mL. As such, the optimal Asp/TLs were shown to increase the cytotoxic activity of Asp by 4-fold upon exposure to mild hyperthermia. The IC values of Asp and Asp/TLs without exposure to 40 °C were 6.6 μg mL and 186 μg mL, respectively. This indicated that Asp was released only when placed at 40 °C. The apoptosis assay revealed that Asp/TLs (40 °C) caused a remarkable increase in the percentage of cell population among both the late apoptosis and necrosis quartiles, as well as a significant decline in the viable cell quartile ( ≤ 0.001) when compared to Asp (40 °C). Asp/TLs (40 °C) and Asp (40 °C) could stimulate the intrinsic apoptosis pathway by upregulating the apoptotic genes and , while downregulating the anti-apoptotic genes, and . The free Asp (40 °C) increased the gene expression of and by 4.4- and 5.2-folds, while reducing the expression of and by 50% and 73%, respectively. The optimal Asp TLs (40 °C) manifested more potent effects as demonstrated by the upregulation of , , and by 5.6-, 7.2-, and 1.3-folds, as well as the downregulation of and by 70% and 85%, respectively. As such, the optimal Asp TLs (40 °C) treatment displayed the most potent cytotoxic profile and induced both apoptosis and necrosis in MDA-MB-231.

Citing Articles

Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances.

Laila U, Zhao Z, Liu H, Xu Z Int J Nanomedicine. 2025; 20:2327-2365.

PMID: 40017626 PMC: 11866938. DOI: 10.2147/IJN.S505636.


PEGylated Nanoliposomes Encapsulated with Anticancer Drugs for Breast and Prostate Cancer Therapy: An Update.

Peter S, Khwaza V, Alven S, Naki T, Aderibigbe B Pharmaceutics. 2025; 17(2).

PMID: 40006557 PMC: 11859135. DOI: 10.3390/pharmaceutics17020190.


Extracellular vesicles: from intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics.

Mohamed A, Abaza T, Youssef Y, Rady M, Fahmy S, Kamel R Nanoscale Adv. 2025; 7(4):934-962.

PMID: 39823046 PMC: 11733735. DOI: 10.1039/d4na00393d.


Sustainable Nanomedicine: Enhancement of Asplatin's Cytotoxicity In Vitro and In Vivo Using Green-Synthesized Zinc Oxide Nanoparticles Formed via Microwave-Assisted and Gambogic Acid-Mediated Processes.

Hassan H, Sedky N, Nafie M, Mahdy N, Fawzy I, Fayed T Molecules. 2024; 29(22).

PMID: 39598716 PMC: 11596978. DOI: 10.3390/molecules29225327.


Synergistic Enhancement of Carboplatin Efficacy through pH-Sensitive Nanoparticles Formulated Using Naturally Derived Extract for Colorectal Cancer Therapy.

Fahmy S, Sedky N, Hassan H, Abdel-Kader N, Mahdy N, Amin M Pharmaceutics. 2024; 16(10).

PMID: 39458611 PMC: 11510476. DOI: 10.3390/pharmaceutics16101282.


References
1.
Lokich J, Anderson N . Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol. 1998; 9(1):13-21. DOI: 10.1023/a:1008215213739. View

2.
Zhang C, Xu C, Gao X, Yao Q . Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics. 2022; 12(5):2115-2132. PMC: 8899578. DOI: 10.7150/thno.69424. View

3.
Levine A, Hu W, Feng Z . The P53 pathway: what questions remain to be explored?. Cell Death Differ. 2006; 13(6):1027-36. DOI: 10.1038/sj.cdd.4401910. View

4.
Fahmy S, Azzazy H, Schaefer J . Liposome Photosensitizer Formulations for Effective Cancer Photodynamic Therapy. Pharmaceutics. 2021; 13(9). PMC: 8470396. DOI: 10.3390/pharmaceutics13091345. View

5.
Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View